RxDoctor Payments Data

Jacob Smith, MD

Plastic Surgery · Leawood, KSNPI 1306378195

Payments from drug & device makers

What this record shows

AbbVie accounts for 62.0% of it on its own, with 22 other manufacturers making up the rest. Reporting peaked in 2023 at $2,879 and has fallen 75.3% since, to $712 in 2025.

$3,839in general payments, 2019–2025

Across 66 payments — averaging $58.17 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$2K
  • Motiva USA, LLC$321
  • Integra Lifesciences Corporation$214
  • Axogen$184
  • Innovation Technologies Inc$118
  • Kerecis Limited$90
  • plus $532 from 17 others

What the payments were for

  • Travel & lodging$1,74045%
  • Food & beverage$2,09955%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$3,839 in reported general payments places this provider in the 65th percentile of 42 plastic surgery providers in Kansas.

See all plastic surgery providers in Kansas

Medicare billing

Part B allowed, 2024
$37,239
Medicare patients
125
Services billed
268

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Tobramycin-DexamethasoneTobramycin/Dexamethasone25$1,170
ErythromycinErythromycin Base38$402
Ondansetron OdtOndansetron29$356
Oxycodone Hcl35$84

Paid to pharmacies, not to this prescriber.

Other plastic surgery in Leawood

See the full list for Kansas

Where these figures come from

Is this you, or does something look wrong? →